Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,149,450 | 6,857,780 | 5,323,320 | 5,816,370 | 8,659,600 |
| Marketable Securities | 354,340 | 467,880 | 264,230 | 253,240 | 345,820 |
| Receivables | 7,808,690 | 8,664,130 | 8,616,960 | 8,982,770 | 8,717,500 |
| Inventories | 6,973,110 | 7,141,850 | 6,918,810 | 6,774,730 | 6,102,720 |
| Other current assets | 1,905,220 | 1,701,090 | 1,686,370 | 96,010 | 1,560 |
| TOTAL | $24,190,810 | $24,832,730 | $22,809,690 | $21,923,120 | $23,827,200 |
| Non-Current Assets | |||||
| Investments And Advances | 2,396,330 | 2,332,710 | 2,696,160 | 2,505,970 | 2,387,880 |
| Other Non-Current Assets | 25,491,150 | 25,429,260 | 25,292,110 | 26,723,180 | 25,758,160 |
| TOTAL | $27,887,480 | $27,761,970 | $27,988,270 | $29,229,150 | $28,146,040 |
| Total Assets | $66,996,910 | $67,346,310 | $65,384,550 | $65,723,020 | $65,856,170 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,115,570 | 12,601,010 | 11,695,160 | 12,082,960 | 13,014,440 |
| Accrued Expenses | 1,557,450 | 2,145,560 | 2,044,840 | 2,265,960 | 2,272,080 |
| Other current liabilities | 2,388,090 | 1,846,450 | 1,590,430 | 1,888,580 | 1,751,010 |
| TOTAL | $21,911,480 | $25,516,170 | $20,620,110 | $19,311,210 | $21,401,760 |
| Non-Current Liabilities | |||||
| Long Term Debt | 26,107,550 | 22,757,340 | 24,415,280 | 25,460,280 | 24,185,540 |
| Other Non-Current Liabilities | 10,109,440 | 8,406,800 | 7,669,430 | 7,517,910 | 6,960,230 |
| TOTAL | $36,950,390 | $32,221,880 | $33,259,440 | $34,112,000 | $32,230,170 |
| Total Liabilities | $58,861,890 | $57,738,060 | $53,879,560 | $53,423,230 | $53,631,950 |
| Shareholders' Equity | |||||
| Common Shares | 2,206,800 | 2,235,790 | 2,251,850 | 2,213,000 | 2,090,570 |
| Retained earnings | -3,418,150 | -1,988,490 | -265,910 | 791,180 | 1,428,660 |
| Other shareholders' equity | 4,799,270 | 4,820,850 | 4,964,850 | 4,867,950 | 4,644,330 |
| TOTAL | $8,135,020 | $9,608,250 | $11,504,980 | $12,299,790 | $12,224,210 |
| Total Liabilities And Equity | $66,996,910 | $67,346,310 | $65,384,540 | $65,723,020 | $65,856,160 |